Thiamine-responsive megaloblastic anemia (TRMA syndrome), also known as Rogers syndrome, is usually associated with non-autoimmune early-onset diabetes mellitus, anemia and sensorineural deafness due to autosomal recessive mutations in the SLC19A2 gene that encodes thiamine transporter. Here, SLC19A2 is linked to anemia (phenotype).